Moreover, some studies reported better clinical results such as low grade tumours and better survival in patients with right-sided RCC compared with the left-sided RCC [34,35], but our result shows no significant difference between the expression level of RGS5 in female versus male patients with primary tumours located in the right kidney. The gene discussed is RGS5; the disease is renal cell carcinoma.